Reviva Pharmaceuticals I...

NASDAQ: RVPH · Real-Time Price · USD
0.35
-0.41 (-54.17%)
At close: Jun 26, 2025, 3:59 PM

Reviva Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-29.92M -39.26M -24.34M -8.52M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
1.63M 3.41M 176.74K 106.71K
Other Working Capital
-6.83M 6.96M 2M -203.71K
Other Non-Cash Items
-717.64K 239.22K 194.71K -1.55M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.54M 7.28M 5.01M -702.17K
Operating Cash Flow
-33.54M -28.32M -18.96M -10.67M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
458.15K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 5.68M 18.97K 98.48K
Financial Cash Flow
23.65M 33.17M 7.79M 31.6M
Net Cash Flow
-9.89M 4.85M -11.17M 20.93M
Free Cash Flow
-33.54M -28.32M -18.96M -10.67M